Educational Programs

Upcoming Program

The Value of Medication Monitoring: Workers’ Compensation Claimants and Systems

Thursday, May 25, 2017
Online @ 10AM PST / 1PM EST

According to the latest Worker’s Compensation Research Institute Opioid Study a large percentage of injured workers (54-86%) receiving pain medications received opioids across the 25 states studied. Numerous guidelines have been published to address the appropriate utilization of opioid therapy in the worker’s compensation population.  This presentation will highlight national trends in opioid misuse and abuse, discuss patient selection and discuss the role of medication monitoring as a valuable tool that provides objective, actionable information during the care of injured workers. 

Objectives: Upon completion of this session participants will be able to:

  • Describe trends in opioid misuse and abuse
  • Discuss the current landscape in use of opioids for chronic pain management
  • Discuss guidelines created specifically for worker’s compensation
  • Identify risk factors for substance misuse and abuse

Archived Program

Personalizing Medication Management with Pharmacogenetic Testing (PGT) in Mental Health

Thursday, February 16, 2017
Online @ 10:00 AM PDT

Variability in medication response among patients being treated for mental health disorders is a well-known challenge for clinicians, often leading to multiple medication trials to find the regimen which is effective without intolerable side effects. PGT helps clinicians move beyond trial and error to make more effective prescribing decisions that are personalized for each patient. Focusing on case studies in mental health, this program will demonstrate how a patient’s genetic profile may impact his or her response to certain medications.

Objectives: Upon completion of this session participants will be able to:

  • Explain how genetic variability may influence medication efficacy and toxicity
  • Discuss how genetic variations may allow clinicians to more effectively understand medication response
  • Understand how PGT may provide valuable, objective information for more personalized therapy in mental health

Archived Program

Urine Drug Testing Interpretation: A Toxicologist’s Perspective on Common Clinical Challenges

Tuesday, August 16, 2016
Online @ 10:00 AM PDT

Interpreting urine drug testing (UDT) results can present clinicians a host of challenges. Assessing specimen tampering, marijuana abstinence, and alcohol consumption are particularly challenging, common scenarios. This case-based program, led by toxicologists, will highlight these difficult scenarios, giving clinicians a greater understanding of each to support improved clinical decision making.

Objectives: Upon completion of this session participants will be able to:

  • Briefly overview the clinical use of urine drug testing
  • Identify the major markers that constitute specimen validity testing and what each means to UDT interpretation
  • Recognize ways patients may attempt to circumvent UDT through dilution, adulteration and substitution methods
  • Utilize tools and resources to create risk management plans for patients in practice
  • Discuss UDT interpretation of alcohol use

Archived Program

Managing Risk in the Treatment of Chronic Pain

Thursday, June 16, 2016
Online @ 10:00 AM PDT

Utilizing opioid therapy for the management of chronic pain must involve careful patient selection and evaluation of risk versus benefit, including the risks of misuse, abuse, diversion, overdose, and substance use disorders. Chronic opioid therapy should also be accompanied by an ongoing, multifaceted monitoring plan. Through discussion of current literature and case study application, this program outlines the necessary steps to evaluate risk, stratify patients, and create a monitoring plan based on individual risk level. Relevant tools and resources are provided for practical application and creation of risk management plans in clinical practice.

Objectives: Upon completion of this session participants will be able to:

  • Discuss the current landscape in use of opioids for chronic pain management
  • Identify the steps to a chronic opioid therapy risk management plan
  • Create a risk management plan based on patient case
  • Utilize tools and resources to create risk management plans for patients in practice

Archived Program

Urine Drug Testing (UDT) in Substance Use Disorder (SUD) Treatment: A Consensus-Based Ethical Approach

Thursday, April 14, 2016
Online @ 10:00 AM PDT

What are the concerns related to appropriate utilization of UDT in the diagnosis and treatment of SUDs?  Featuring Michael C. Barnes, Esq., executive director of the Center for Lawful Access and Abuse Deterrence (CLAAD), and Kenneth L. Kirsh, PhD, clinical psychologist, author and lecturer on pain and addiction, this webcast will describe a clinical approach for utilizing UDT in the treatment of SUDs.  Scenarios which may give rise to civil and criminal liability, with examples of government and payer policy responses, will be presented during this educational program.

Objectives: Upon completion of this session participants will be able to:

  • Identify concerns related to the appropriate use of UDT in the diagnosis and treatment of SUDs.
  • Describe a clinical approach for utilizing UDT in the identification and management of SUDs.
  • Recognize scenarios that may give rise to civil and criminal liability for practitioners related to waste, fraud and abuse in UDT.
  • Be aware of government and payer policy responses to UDT utilization concerns.

Archived Program

Trends in Opioid Misuse and Abuse

Tuesday, February 9, 2016
Online @ 10:00 AM PDT

Rates of prescription opioid medication misuse remain high, but have leveled in comparison to a sharp increase in heroin abuse.Featuring renowned lecturer, writer, and researcher, Dr. Jeffrey Fudin, and nationally recognized pain educator of the year, Dr.Leah LaRue, this program will illustrate recent trends in opioid use, and naturally occurring kratom (mitragynine), and discuss pharmacology and physical effects. Consequences to public health continue to emerge and require a multi-pronged approach to mitigate the risks associated with opioid misuse, abuse, and addiction before, during and following clinic evaluation.

Objectives: Upon completion of this session participants will be able to:

  • Identify contemporary landscape and changing trends in opioid misuse and abuse.
  • Articulate specific chemical and therapeutic differences among common opioids.
  • Describe consequences of opioid misuse, abuse, and addiction.
  • Discuss efforts designed to mitigate the risk associated with opioid use.

Archived Program

Appropriate Urine Drug Testing in Substance Use Disorders: Clinical Consensus Recommendations

Tuesday, November 10, 2015
Online @ 10:00 AM PDT

When used appropriately, urine drug testing and medication monitoring in substance use disorders can provide objective data that healthcare practitioners may employ in the diagnosis, active treatment, and recovery phases of care. A project to develop professional consensus on the appropriate use of UDT in identifying and treating substance use disorders was necessitated by a general lack of clinical knowledge and standards. This presentation will focus on a review of clinical indicators, scientific methods, patient-centered substance use testing, and the recommendations on testing from this clinical consensus project.

Objectives: Upon completion of this session participants will be able to:

  • Discuss the clinical need and value of UDT in the diagnosis and treatment of SUD.
  • Outline the clinical consensus recommendations for UDT in diagnosis and treatment of SUD related to:
    • Test methods & selection
    • Practice recommendations
    • Test frequency based on stages of treatment and recovery
  • List reasons for medically necessary and appropriate UDT.
  • Document reasons for drug testing, review of test results and use of results in the treatment plan to support medical necessity.